Silvant Capital Management LLC Vertex Pharmaceuticals Inc Transaction History

Silvant Capital Management LLC

$2.23 Billion
Q3 2024

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 08, 2021	SELL	$181.39 - $202.99 $1.95 Million - $2.18 Million	-10,731 Closed	0 $0
Q2 2021 Aug 03, 2021	SELL	$187.49 - $221.1 $34,873 - $41,124	-186 Reduced 1.7%	10,731 $2.16 Million
Q1 2021 May 11, 2021	SELL	$207.02 - $241.31 $71,421 - $83,251	-345 Reduced 3.06%	10,917 $2.35 Million
Q4 2020 Feb 05, 2021	BUY	$207.01 - $276.09 $19,872 - $26,504	96 Added 0.86%	11,262 $2.66 Million
Q3 2020 Nov 09, 2020	SELL	$255.65 - $303.1 $765,671 - $907,784	-2,995 Reduced 21.15%	11,166 $3.04 Million
Q2 2020 Aug 11, 2020	SELL	$225.48 - $295.8 $213,980 - $280,714	-949 Reduced 6.28%	14,161 $4.11 Million
Q1 2020 May 13, 2020	SELL	$199.77 - $247.81 $59,731 - $74,095	-299 Reduced 1.94%	15,110 $3.6 Million
Q4 2019 Feb 10, 2020	SELL	$166.71 - $223.91 $31,508 - $42,318	-189 Reduced 1.21%	15,409 $3.37 Million
Q3 2019 Nov 12, 2019	SELL	$166.23 - $187.09 $354,069 - $398,501	-2,130 Reduced 12.01%	15,598 $2.64 Million
Q2 2019 Aug 09, 2019	SELL	$164.61 - $190.37 $277,532 - $320,963	-1,686 Reduced 8.68%	17,728 $3.25 Million
Q1 2019 May 10, 2019	SELL	$163.73 - $194.7 $133,439 - $158,680	-815 Reduced 4.03%	19,414 $3.57 Million
Q4 2018 Feb 06, 2019	SELL	$151.91 - $192.21 $91,297 - $115,518	-601 Reduced 2.89%	20,229 $3.35 Million
Q3 2018 Nov 07, 2018	SELL	$167.73 - $192.74 $585,713 - $673,048	-3,492 Reduced 14.36%	20,830 $4.02 Million
Q2 2018 Aug 13, 2018	SELL	$145.72 - $169.96 $41,530 - $48,438	-285 Reduced 1.16%	24,322 $4.13 Million
Q1 2018 May 09, 2018	BUY	$151.6 - $177.13 $3.73 Million - $4.36 Million	24,607 New	24,607 $4.01 Million

Others Institutions Holding VRTX

# of Institutions

1,724

Shares Held

222M

Call Options Held

1.58M

Put Options Held

1.36M

Capital World Investors Los Angeles, CA

26.8M
Shares

$12.5 Billion
1.99% of portfolio
Vanguard Group Inc Valley Forge, PA

23.2M
Shares

$10.8 Billion
0.2% of portfolio
Black Rock Inc. New York, NY

21.3M
Shares

$9.9 Billion
0.23% of portfolio
State Street Corp Boston, MA

11.8M
Shares

$5.49 Billion
0.23% of portfolio
Capital Research Global Investors Los Angeles, CA

9M
Shares

$4.18 Billion
0.9% of portfolio

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $119B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Silvant Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Silvant Capital Management LLC with notifications on news.

Account